EXPRES2ION BIOTECHNOLOGIES ApS: Financial statements 2021
CVR: 32770487
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
EXPRES2ION BIOTECHNOLOGIES ApS (CVR 32770487) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -7,806,372 and a net result of DKK -27,224,687 compared with DKK -18,365,182 the year before. Equity in the 2021 report amounted to DKK 97,267,763. The solvency ratio was 91.4%. The company had 21 employees in the financial year.
- Gross Profit
- DKK -7,806,372
- Profit/Loss
- DKK -27,224,687
- Equity
- DKK 97,267,763
- Total Assets
- DKK 106,378,560
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -7.8M | -27.2M | 97.3M | 21 |
| 2020 | - | -7M | -18.4M | 64.3M | 16 |
| 2019 | - | 2.8M | -8.6M | -3.7M | 15 |
| 2018 | - | 510K | -9.8M | -14.3M | 15 |
| 2017 | - | 2.5M | -5.1M | -4.6M | 11 |
Official annual report
Find more companies like EXPRES2ION BIOTECHNOLOGIES ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2020. Gross profit came to DKK -7,043,885, and the net result was DKK -18,365,182.
As of June 2, 2021, Karin Garre has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of June 2, 2021, Sara Sande has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of June 2, 2021, Gitte Laurette Pedersen-Botero has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
About EXPRES2ION BIOTECHNOLOGIES ApS
EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.